PriceTargets.com logo

EKF Diagnostics - EKF Stock Price Target and Predictions

  • Consensus Rating: Buy
  • Consensus Price Target: GBX 35
  • Forecasted Upside: 40.00%
  • Number of Analysts: 1
  • Breakdown:
  • 0 Sell Ratings
  • 0 Hold Ratings
  • 1 Buy Ratings
  • 0 Strong Buy Ratings
GBX 25 As of 07/10/2026 06:01 AM ET
▼ -0.6 (-2.34%)

This chart shows the closing price for EKF by one month, three months, or twelve months.

Skip Closing Price Chart
1 month | 3 months | 12 months
Get New EKF Diagnostics Analyst Ratings Delivered To Your Inbox
Sign-up to receive the latest news and ratings for EKF and its competitors with Analyst Ratings Network’s free daily newsletter.

Analyst Price Target for EKF

Analyst Price Target is GBX 35
▲ +40.00% Upside Potential
This price target is based on 1 analysts offering 12 month price targets for EKF Diagnostics in the last 3 months. The average price target is GBX 35, with a high forecast of GBX 35 and a low forecast of GBX 35. The average price target represents a 40.00% upside from the last price of GBX 25.

This chart shows the closing price for EKF for the last year in relation to the current analyst high, average, and low pricetarget.

Read Analyst Price Chart DescriptionSkip Analyst Price Chart




Current Consensus is Buy

The current consensus among 1 investment analysts is to buy stock in EKF Diagnostics.

Past Monthly Recommendations

Move your mouse over past months for details

Read Past Recommendations DescriptionSkip Past Price Target Consensus Chart
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
Ratings as of
1/15/2025
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
Ratings as of
4/15/2025
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
Ratings as of
7/14/2025
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
Ratings as of
10/12/2025
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
Ratings as of
1/10/2026
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
Ratings as of
4/10/2026
  • 0 strong buy ratings
  • 1 buy ratings
  • 0 hold ratings
  • 0 sell ratings
Ratings as of
6/9/2026
  • 0 strong buy ratings
  • 1 buy ratings
  • 0 hold ratings
  • 0 sell ratings
Ratings as of
7/9/2026

Latest Recommendations

  • 0 strong buy ratings
  • 1 buy ratings
  • 0 hold ratings
  • 0 sell ratings

Display Ratings By
DateBrokerageActionRatingPrice TargetDetails
4/22/2026Stifel NicolausReiterated RatingBuyGBX 35 ➝ GBX 35
(Data available from 7/10/2021 forward)

News Sentiment Rating

0.67 (Buy)

Our news sentiment rating is based on the average sentiment of articles about this company published in the media in the last 30 days of headlines and can range from 2 (very positive sentiment) to -2 (very negative sentiment).

News Sentiment Over Time

Move your mouse over past months for details

Skip to Current Sentiment Summary
  • 0 very positive mentions
  • 3 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
12/12/2025
  • 1 very positive mentions
  • 1 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
1/11/2026
  • 0 very positive mentions
  • 1 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
2/10/2026
  • 0 very positive mentions
  • 1 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
3/12/2026
  • 1 very positive mentions
  • 1 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
4/11/2026
  • 0 very positive mentions
  • 2 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
5/11/2026
  • 1 very positive mentions
  • 1 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
6/10/2026
  • 0 very positive mentions
  • 1 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
7/10/2026

Current Sentiment

  • 0 very positive mentions
  • 1 positive mentions
  • 0 negative mentions
  • 0 very negative mentions

Recent Stories by Sentiment

Very Negative

  • No very negative mentions tracked during this time.

Negative

  • No negative mentions tracked during this time.

Positive

Very Positive

  • No very positive mentions tracked during this time.
EKF Diagnostics logo
EKF is an AIM-listed global diagnostics business focussed on: ● Point-of-Care analysers in the key areas of Hematology and Diabetes ● Life Sciences services provide specialist manufacture of enzymes and custom products for use in diagnostic, food and industrial applications. EKF has headquarters in Penarth (near Cardiff) and operates five manufacturing sites across the US and Germany, selling into over 120 countries world-wide.
Read More

Today's Range

Now: GBX 25
Low: 25
High: 26.06

50 Day Range

MA: GBX 26.29
Low: 24.50
High: 28

52 Week Range

Now: GBX 25
Low: 22
High: 32

Volume

43,377 shs

Average Volume

328,537 shs

Market Capitalization

£107.57 million

P/E Ratio

53.19

Dividend Yield

4.65%

Beta

0.513

Frequently Asked Questions

What sell-side analysts currently cover shares of EKF Diagnostics?

The following sell-side analysts have issued stock ratings on EKF Diagnostics in the last year: Stifel Nicolaus.
View the latest analyst ratings for EKF.

What is the current price target for EKF Diagnostics?

0 Wall Street analysts have set twelve-month price targets for EKF Diagnostics in the last year. Their average twelve-month price target is GBX 35, suggesting a possible upside of 40.0%. Stifel Nicolaus has the highest price target set, predicting EKF will reach GBX 35 in the next twelve months. Stifel Nicolaus has the lowest price target set, forecasting a price of GBX 35 for EKF Diagnostics in the next year.
View the latest price targets for EKF.

What is the current consensus analyst rating for EKF Diagnostics?

EKF Diagnostics currently has 1 buy rating from Wall Street analysts. The stock has a consensus analyst rating of "Buy." A "buy" rating indicates that analysts believe EKF will outperform the market and that investors should add to their positions of EKF Diagnostics.
View the latest ratings for EKF.

What other companies compete with EKF Diagnostics?

Other companies that are similar to EKF Diagnostics include NIOX Group, Creo Medical Group, Intelligent Ultrasound Group, Novacyt and Inspiration Healthcare Group. Learn More about companies similar to EKF Diagnostics.

How do I contact EKF Diagnostics' investor relations team?

EKF Diagnostics' physical mailing address is Avon HSE, 19 Stanwell Road, PENARTH, CF64 2EZ, United Kingdom. The company's listed phone number is +44-29-20710570. The official website for EKF Diagnostics is www.ekfdiagnostics.com. Learn More about contacing EKF Diagnostics investor relations.